5021 - 5030 of 8620 Results
Title
Year
- Prevalence of impaired odor identification in Parkinson disease with imaging evidence of nigrostriatal denervation2016OPENTitle: Prevalence of impaired odor identification in Parkinson disease with imaging evidence of nigrostriatal denervationJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 123Issue #: 4Start Page: 421End Page: 424Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00702-016-1524-7Best OA location URL: http://doi.org/10.1007/s00702-016-1524-7Citation Count: 28
-
RESTRICTEDTitle: Which dyskinesia scale best detects treatment response?Journal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 3Start Page: 341End Page: 346Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25321Citation Count: 82
- Erythropoietin and small molecule agonists of the tissue-protective erythropoietin receptor increase FXN expression in neuronal cells in vitro and in Fxn-deficient KIKO mice in vivo2017RESTRICTEDTitle: Erythropoietin and small molecule agonists of the tissue-protective erythropoietin receptor increase FXN expression in neuronal cells in vitro and in Fxn-deficient KIKO mice in vivoJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 123Issue #:Start Page: 34End Page: 45Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2017.05.011Citation Count: 11
-
OPENTitle: Body-first versus brain-first biological subtyping of Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 143Issue #: 10Start Page: 2871End Page: 2873Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awaa293Best OA location URL: https://academic.oup.com/brain/article-pdf/143/10/2871/35939469/awaa293.pdfCitation Count: 21
- Synapsin III gene silencing redeems alpha-synuclein transgenic mice from Parkinson's disease-like phenotype2022OPENTitle: Synapsin III gene silencing redeems alpha-synuclein transgenic mice from Parkinson's disease-like phenotypeJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 30Issue #: 4Start Page: 1465End Page: 1483Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ymthe.2022.01.021Best OA location URL: http://www.cell.com/article/S1525001622000211/pdfCitation Count: 15
- Gba1 E326K renders motor and non-motor symptoms with pathological α-synuclein, tau and glial activation2024RESTRICTEDTitle: Gba1 E326K renders motor and non-motor symptoms with pathological α-synuclein, tau and glial activationJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 147Issue #: 12Start Page: 4072End Page: 4083Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/brain/awae222Citation Count: 2
- The PINK1—Parkin mitophagy signalling pathway is not functional in peripheral blood mononuclear cells2021OPENTitle: The PINK1—Parkin mitophagy signalling pathway is not functional in peripheral blood mononuclear cellsJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 16Issue #: 11Start Page: e0259903End Page: e0259903Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0259903Best OA location URL: https://doi.org/10.1371/journal.pone.0259903Citation Count: 18
-
OPENTitle: Validation of differentially expressed brain‐enriched microRNAs in the plasma of PD patientsJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 7Issue #: 9Start Page: 1594End Page: 1607Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.51146Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51146Citation Count: 54
- Activation and Purification of ß‐Glucocerebrosidase by Exploiting its Transporter LIMP‐2 – Implications for Novel Treatment Strategies in Gaucher's and Parkinson's Disease2024OPENTitle: Activation and Purification of ß‐Glucocerebrosidase by Exploiting its Transporter LIMP‐2 – Implications for Novel Treatment Strategies in Gaucher's and Parkinson's DiseaseJournal Name: Advanced SciencePublisher: WileyVol: 11Issue #: 25Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/advs.202401641Best OA location URL: https://doi.org/10.1002/advs.202401641Citation Count: 3
- Distinctive CD56dim NK subset profiles and increased NKG2D expression in blood NK cells of Parkinson’s disease patients2024OPENTitle: Distinctive CD56dim NK subset profiles and increased NKG2D expression in blood NK cells of Parkinson’s disease patientsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00652-yBest OA location URL: https://www.nature.com/articles/s41531-024-00652-y.pdfCitation Count: 4